Personal information

No personal information available

Activities

Collapse all

Employment (3)

Gilead Sciences, Inc.: Foster City, CA, US

2019-10-14 to present | Director (Virology)
Employment
Source: Self-asserted source
John Bilello

Merck and Co Inc West Point: West Point, PA, US

2014-08-04 to 2019-10-10 | Principal Scientist (Infectious Diseases)
Employment
Source: Self-asserted source
John Bilello

Idenix Pharmaceuticals, Inc.: Cambridge, MA, US

2007-03-07 to 2014-08-04 | Director (Biology)
Employment
Source: Self-asserted source
John Bilello

Education and qualifications (1)

Pennsylvania State University: University Park, PA, US

1998-07-15 to 2002-06-17 | PhD (Microbiology/Cell and Molecular Biology)
Education
Source: Self-asserted source
John Bilello

Works (1)

Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron Variants

Viruses
2025-01 | Journal article | Author
DOI: 10.3390/v17020168
Contributors: Lauren Rodriguez; J. Lizbeth Reyes Zamora; Dong Han; Jasmine Moshiri; Nadine Peinovich; Clarissa Martinez; Pui Yan Ho; Jiani Li; Thomas Aeschbacher; Ross Martin et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Peer review (1 review for 1 publication/grant)

Review activity for Antiviral research. (1)
How many people are using ORCID?